Quest Diagnostics Incorporated (DGX)

NYSE: DGX · Real-Time Price · USD

255.60

+8.54 (3.46%)

At close: Nov 4, 2026, 4:00 PM EST

255.62

+0.02 (0.01%)

After-hours: Nov 4, 2026, 7:30 PM EST

Quest Diagnostics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	28,121	19,304	16,838	15,503	17,817	21,224
Market Cap Growth	43.67%	14.64%	8.62%	-12.99%	-16.05%	32.15%
Enterprise Value	33,721	25,369	23,156	20,386	21,871	25,006
Last Close Price	255.68	170.66	145.61	130.28	144.84	157.08

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	25.47	19.54	19.44	18.24	18.91	10.68
Forward PE	22.03	17.07	15.97	15.53	18.91	18.61
PS Ratio	2.38	1.75	1.71	1.68	1.80	1.97
PB Ratio	3.69	2.65	2.44	2.42	2.97	3.23
P/FCF Ratio	20.46	14.20	18.52	17.94	13.56	11.60
P/OCF Ratio	14.42	10.24	12.62	12.19	10.37	9.51
PEG Ratio	2.35	2.04	2.42	13.49	13.49	13.49

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	2.85	2.30	2.35	2.20	2.21	2.32
EV/EBITDA Ratio	14.34	11.66	12.14	11.62	11.31	8.93
EV/EBIT Ratio	19.09	15.81	16.38	15.49	14.61	10.45
EV/FCF Ratio	24.53	18.67	25.47	23.59	16.64	13.66

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.80	0.90	1.03	0.86	0.79	0.73
Debt / EBITDA Ratio	2.23	2.49	3.08	2.61	2.07	1.53
Debt / FCF Ratio	4.65	4.85	7.83	6.36	3.59	2.61
Net Debt / Equity Ratio	0.70	0.85	0.95	0.75	0.73	0.59
Net Debt / EBITDA Ratio	2.38	2.83	3.45	2.74	2.28	1.38
Net Debt / FCF Ratio	4.07	4.54	7.23	5.57	3.35	2.11
Asset Turnover	0.71	0.68	0.65	0.69	0.75	0.78
Inventory Turnover	39.17	39.03	34.92	32.39	32.16	30.49
Quick Ratio	1.37	0.80	0.85	1.05	0.97	1.34
Current Ratio	1.70	1.04	1.10	1.31	1.22	1.56
Return on Equity (ROE)	15.32%	14.75%	13.84%	14.62%	16.15%	30.92%
Return on Assets (ROA)	6.61%	6.20%	5.86%	6.13%	7.07%	10.82%
Return on Invested Capital (ROIC)	10.03%	9.17%	8.83%	9.55%	11.41%	17.74%
Return on Capital Employed (ROCE)	11.50%	11.50%	10.10%	10.80%	13.30%	20.20%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	3.93%	5.14%	5.17%	5.51%	5.31%	9.40%
FCF Yield	4.89%	7.04%	5.40%	5.57%	7.38%	8.62%
Dividend Yield	1.35%	1.82%	1.98%	2.03%	1.65%	1.39%
Payout Ratio	34.27%	35.59%	38.00%	36.77%	32.24%	15.49%
Buyback Yield / Dilution	1.32%	-	0.89%	4.24%	7.81%	5.88%
Total Shareholder Return	2.67%	1.82%	2.87%	6.27%	9.46%	7.27%

SEC Filings: 10-K · 10-Q